1. Home
  2. PUBM vs MRVI Comparison

PUBM vs MRVI Comparison

Compare PUBM & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PubMatic Inc.

PUBM

PubMatic Inc.

SELL

Current Price

$18.77

Market Cap

772.5M

Sector

Technology

ML Signal

SELL

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

SELL

Current Price

$8.57

Market Cap

1.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PUBM
MRVI
Founded
2006
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
772.5M
1.0B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
PUBM
MRVI
Price
$18.77
$8.57
Analyst Decision
Buy
Buy
Analyst Count
13
8
Target Price
★ $21.00
$7.60
AVG Volume (30 Days)
650.9K
★ 2.2M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 14.29
EPS
N/A
★ N/A
Revenue
★ $282,926,000.00
$185,743,000.00
Revenue This Year
$9.05
$14.01
Revenue Next Year
$8.32
$6.09
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$6.15
$2.55
52 Week High
$19.30
$9.42

Technical Indicators

Market Signals
Indicator
PUBM
MRVI
Relative Strength Index (RSI) 65.18 68.21
Support Level $15.79 $5.54
Resistance Level $19.19 $9.42
Average True Range (ATR) 0.68 0.40
MACD 0.09 0.09
Stochastic Oscillator 81.91 97.67

Price Performance

Historical Comparison
PUBM
MRVI

About PUBM PubMatic Inc.

PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: